Novel influenza treatment developed through inducing mutations in the viral genome
A novel influenza therapy has been developed, capable of inducing mutations in the viral genome to prevent viral replication and avoiding resistance, reports the Institute for Biomedical Sciences at Georgia State University (GA, USA).
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>